Abstract:Background: Genetic overexpression or pharmacological activation of heme oxygenase (HO) are identified as potential therapeutic target for spinal cord injury (SCI); however, the role of carbon monoxide (CO), which is a major product of haem degenerated by HO, in SCI remains unknown. Applying hemin or chemicals which may regulate HO expression or activity to increase CO production are inadequate to elaborate the direct role of CO. Here, we respond to this question and explain its possible protective mechanism. Methods: Rat SCI model was performed with a vascular clip (30g) compressing at T9 vertebral level for 1min and CO was delivered immediately after SCI by CO releasing molecule 3 (CORM-3), the classical donor of CO. The neurological deficits and neuron survival were assessed. Inflammasome activation and inositol-requiring enzyme 1 (IRE1) pathway were measured by various molecular biological methods. For in vitro study, oxygen glucose deprivation (OGD) simulated the SCI-inflammasome activation in cultured the primary neurons. Findings: CORM-3 restrained inflammasome activation and pyroptosis occurrence, which consequently relieved neuron death and improved motor functional recovery following SCI. As a pivotal sensor involving in endoplasmic reticulum stress-medicated inflammasome activation, IRE1 and its downstream X-box binding protein 1 (XBP1) were activated in SCI tissues as well as in OGD neurons; while inhibition of IRE1 by STF-083010 in SCI rats or by si-RNA in OGD neurons suppressed inflammasome activation and pyroptosis. Interestingly, the SCI/OGD-stimulated IRE1 activation was attenuated by CORM-3 treatment. Interpretations: CO may alleviate neuron death and improve motor functional recovery in SCI through IRE1 regulation, and administration of CO could be a promising therapeutic strategy for SCI. Funding Statement: This study is supported by National Natural Science Foundation of China (81601963, 81873992, 81572227); Wenzhou Science and Technology Bureau Foundation (Y20170083, Y20170092). Declaration of Interests: The authors declare no competing financial interest. Ethics Approval Statement: The protocol for animal care and use conformed to the Guide for the Care and Use of Laboratory Animals from the National Institutes of Health and was approved by the Animal Care and Use Committee of Wenzhou Medical University

MEK1/2 Inhibition Synergistically Enhances the Preventive Effects of Normobaric Oxygen on Spinal Cord Injury in Decompression Sickness Rats

Hyperbaric oxygen preconditioning reduces the incidence of decompression sickness in rats via nitric oxide.

Signaling pathways involved in HSP32 induction by hyperbaric oxygen in rat spinal neurons.

Exogenous Administration of Carbon Monoxide Alleviates Neuron Death after Spinal Cord Injury via Inflammasome Regulation

Heat-shock protein 70 is involved in hyperbaric oxygen preconditioning on decompression sickness in rats.

Combined Effects of Intravenous Perfluorocarbon Emulsion and Oxygen Breathing on Decompression-Induced Spinal Cord Injury in Rats.

Hyperbaric Oxygen Preconditioning Induces Tolerance Against Oxidative Injury And Oxygen-Glucose Deprivation By Up-Regulating Heat Shock Protein 32 In Rat Spinal Neurons

Hyperbaric oxygen preconditioning attenuates early apoptosis after spinal cord ischemia in rats.

THE EFFECT OF NORMOBARIC OXYGEN ON THE INJURY INDUCED BY FOCAL CEREBRAL ISCHEMIA IN RATS VIA HIF‐1‐NOTCH SIGNAL PATHWAY

Effect of Helium Preconditioning on Neurological Decompression Sickness in Rats.

Propofol Combined with Hyperbaric Oxygen Improves the Prognosis of Spinal Cord Injury in Rats Via MAPK/ERK Signaling Pathway

Functional Recovery in Rat Spinal Cord Injury Induced by Hyperbaric Oxygen Preconditioning

Synergistic neuroprotective effects of hyperbaric oxygen and N-acetylcysteine against traumatic spinal cord injury in rat

Mechanism of Spinal Cord Injury Induced by Decompression Sickness: the Therapeutic Effects of NGF

Benefits of Hyperbaric Oxygen Pretreatment for Decompression Sickness in Bama Pigs

Hyperbaric oxygen therapy and coenzyme Q10 synergistically attenuates damage progression in spinal cord injury in a rat model

Cyclooxygenase-2 Mediates Hyperbaric Oxygen Preconditioning in the Rat Model of Transient Global Cerebral Ischemia

Hyperbaric Oxygen in Combination with Epigallocatechin-3-Gallate Synergistically Enhance Recovery from Spinal Cord Injury in Rats

The Neuroprotective Effect of Autophagy in the Hyperbaric Oxygen Pretreatment to Prevent Spinal Cord Ischemia Reperfusion Injury

Hyperbaric Oxygen Treatment Reduced the Lung Injury of Type II Decompression Sickness.

Early hyperbaric oxygen effects on neuropathic pain and nitric oxide synthase isoforms in CCI rats